Ep. 7 - The True Cost of Treatment: Understanding How to Get the Support You Need
カートのアイテムが多すぎます
カートに追加できませんでした。
ウィッシュリストに追加できませんでした。
ほしい物リストの削除に失敗しました。
ポッドキャストのフォローに失敗しました
ポッドキャストのフォロー解除に失敗しました
-
ナレーター:
-
著者:
概要
Episode Summary: Is addiction treatment expensive? Yes. But is it more expensive than not treating it? In this episode, Henry Maxwell and Stefan Bate pull back the curtain on the financial realities of Substance Use Disorders (SUD). They challenge the "sticker shock" of rehab by comparing it to the lifetime costs of other chronic illnesses like leukemia and diabetes. From the "30-day cure" myth to the hidden drain of lost wages and emergency room visits, this conversation provides a pragmatic, numbers-driven roadmap for families trying to navigate the chaotic behavioral health system without going bankrupt.
In This Episode, We Discuss:
The Chronic Disease Comparison: Why we accept a $200k price tag for cancer treatment but hesitate at the same cost for life-saving addiction care.
The 30-Day Trap: Why dumping your entire savings into a "luxury" first month is often the biggest clinical and financial mistake a family can make.
The Cost of Inaction: A breakdown of the "hidden" expenses of active addiction, including ER visits, legal fees, car insurance spikes, and the "tuition black hole."
Maximizing a Finite Budget: How to stretch resources over a 2-to-3-year recovery arc rather than a 30-day crisis.
The ACL Analogy: Why residential treatment is just the "surgery," and why the "physical therapy" (aftercare) is where the real healing happens.
Key Statistics Mentioned:
Healthcare Expenditure: Individuals with an SUD diagnosis average $26,000 annually in medical costs, compared to $10,000 for the general population.
Lifetime Benchmarks: Acute Myeloid Leukemia treatment averages $239,000; Type 2 Diabetes management for a young adult averages $124,000.
The Recovery Gap: On average, it takes 8 years from the onset of a disorder to reach sustained remission, making long-term financial planning essential.